作者的详细信息

Волочаева, Мария Вячеславовна

期 栏目 标题 文件
编号 6 (2012) Articles PREGNANCY MANAGEMENT IN WOMEN WITH CANCER: 10 YEARS' EXPERIENCE
编号 8 (2013) Articles BREAST CANCER AND PREGNANCY
编号 7 (2014) Articles THE HEALTH OF BABIES BORN TO WOMEN WITH PREGNANCY-ASSOCIATED BREAST CANCER
编号 8 (2016) Articles Identification of preeclampsia-related miRNA by a deep sequencing technique and a real-time quantitative PCR
编号 7 (2018) Articles Role of stem cell dysfunction in the development of great obstetrical syndromes
编号 8 (2018) Articles BLOOD CYTOKINE LEVELS IN NEONATES BORN TO MOTHERS WITH CANCER WHO RECEIVED ANTITUMOR CHEMOTHERAPY DURING PREGNANCY
编号 8 (2021) Articles Current views on the pathogenesis of fetal growth restriction
编号 8 (2022) Articles Fetal growth retardation in the context of fetal programming
编号 8 (2023) Original Articles Diagnostic significance of determining the expression of energy metabolism genes in fetal growth retardation
编号 9 (2023) Original Articles Clinical and anamnestic factors in the prediction and diagnosis of fetal growth restriction
编号 11 (2023) Reviews Molecular genetic markers in the pathogenesis of fetal growth retardation
编号 4 (2024) Original Articles Diagnostic significance of proteome analysis of maternal plasma in fetal growth restriction
编号 5 (2024) Original Articles Prediction of neonatal complications based on quantitative proteome analysisin blood of pregnant women with fetal growth restriction
编号 10 (2024) Original Articles Clinical and anamnestic risk factors and prediction models for the development of fetal growth restriction
编号 10 (2024) Original Articles The effect of incretin hormone GLP-1 on the phenotypic profile of mononuclear cells in fetal growth restriction
编号 2 (2025) Original Articles A model for diagnosing fetal growth restriction using functional diagnostic methods
编号 3 (2025) Original Articles Criteria for assessing fetal neurogenesis dysfunction in early-onset growth restriction using extracellular vesicles
编号 3 (2025) Original Articles Postnatal development in children with growth restriction (follow-up study)